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Summary 
        This study was conducted on 90 subjects whom have visited the AL-Sadder Medical City 
and Al-Hakeem hospital in AL- Najaf governorate between the period extended from February 
to August, 2013. Subjects of this study were seventy chronic or recurrent tonsillitis patients, their 
age ranged from: 4-33 years and comprised of 29 males and 41 females.. In addition, 20 (age-and 
sex-matched) healthy adults without any evidence of chronic inflammatory disease depended as 
the control group. 
        Five milliliters of blood sample collected from each patient , for the purpose of obtaining a 
serum sample and measured the concentration of cytokines using ELISA technique . 
Results showed a significant increase to the high concentration of cytokines : interferon - gamma 
, colony stimulating factor granule cells and mononuclear , in all the groups of patients compared 
with those of healthy control group 
 
1. Introduction 
  Tonsillitis is the inflammation of the tonsils as a result of infection mostly caused by a 
virus especially the Epstein-Barr virus Adenoviruses, influenza virus, para influenza virus and 
Enteroviruses and is often preceded by a cold (a runny nose, cough and sore throat). Fewer 
cases (about one in seven) are caused by bacteria [1].  
The tonsils are an important part of the immune system. They are two lymphatic glands   
located on the back part of the throat. The tonsils are also called the palatine tonsils and they 
can clearly be seen when a person opens up their mouth wide enough for them to be revealed 
[2]. 
          Cytokines are vital in host defence against viral infection, with complex networks and 
pathways [3].    
         Gamma interferon (IFN- γ) was a highly pleiotropic protein secreted mainly by activated T-
lymphocytes and natural killer cells. It is involved in a wide range of physiological processes, 
including antiviral, immunoregulatory and anti-tumour properties, cell proliferation and 
apoptosis, as well as the stimulation and repression of a variety of genes [4]. 
Granulicyte Monocyte – Colony stimulation factors (GM-CSF) is a small glycoprotein growth 
factor, a pleiotropic cytokine that can stimulate the proliferation, maturation and function of 
hematopoietic cells. It is produced by a variety of cell types including T cells, B cells, 
macrophages, mast cells, endothelial cells and fibroblasts in response to cytokine or immune and 
inflammatory stimuli. 
        The current study sets an objective to determin the serum level of cytokines: IFNγ, and 
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        Sadder medical city and Al-Hakeem hospital in AL-Najaf city between Februarys to August 
2013, they were (29 males and 41 females) and their ages ranged between (4-33 years) age. 
physical examination showed exudative tonsillitis accompanied by exudative and/or erosin of the 
oropharyngeal mucosa and cervical lymphadenopathy, were investigated from. 
         Control group is comprised of (20) healthy subjects (9 males and 11 females) without any 
history of hematologic, recurrent upper respiratory tract infection or inflammatory diseases and 
hypertrophy of tonsils. 
         Blood sample were taken 24 hr. prior to tonsillectomy (pre-operative) a volume of 5ml of 
venous blood was withdrawn from each patient under study, were left to coagulated and 
centrifuged at 300 r.p.m and the serum were aspirated to another glass test tube . 
 
Cytokine detection  
The cytokines (Interferon-γ, GM-CSF, were measured using Enzyme-Linked 
Immunossorbant Assay at the Virology department in Al-Sadder medical city in AL- Najaf 
governorate as follow. 
 
Interferon gamma (IFN-γ): 
The AssayMax Human IFN-γ   ELISA kit was performed according to the manufacturing 
company (Assaypro, U.S.A) as follows:  
1. The components of the kits were equilibrated at room temperature before use. 
2. The components of the kits were prepared as follows: 
Reagent Preparation 
Human IFN-γ Microplate 96 wells ready to use 
Human IFN-γ - Standard (2 ng/ml) 
Adding 2ml of EIA Diluent to generate a 
1ng/ml of solution 
Biotinylated  IFN-γ – Antibody Dilute 0.08ml in 8ml MIX Diluent 
EIA Diluent Concentrate Dilute 30ml in 300ml of D.W. 
Wash Buffer Concentrate Dilute 30ml in 600ml of D.W. 
Streptavidin-Peroxidase Conjugate Dilute 0.09ml in 9 ml MIX Diluent 
Chromogen Substrate 8ml ready to use 
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3. The standard solution and the appropriate diluents were prepared as follows: 
Standard Point Dilution 
[IFN-γ] C0NCENTRATION 
(ng/ml) 
P1 Standard (1 ng/ml) 1.000 
P2 1 part P1 + 1 part EIA Diluent 0.500 
P3 1 part P2 + 1 part EIA Diluent 0.250 
P4 1 part P3 + 1 part EIA Diluent 0.125 
P5 1 part P4 + 1 part EIA Diluent 0.063 
P6 1 part P5 + 1 part EIA Diluent 0.031 
P7 1 part P6 + 1 part EIA Diluent 0.016 
P8 EIA Diluent 0.000 
 
Procedure: 
 Fifty μl of Standard (8), controls (20) and samples (70) were added per well. Wells were 
covered with a sealing tape and incubated for two hours. The timer was   started after the 
last sample addition. 
 The microplate was washed six times with 300 μl /wells of Wash Buffer using     
bioeliser washer ELx 50 (biokit, U.S.A). 
 Fifty μl of Biotinylated anti IFN-γ antibody were added to each well and incubated at 
room temperatures for two hours. 
 The microplate was washed as described above. 
 Fifty μl of Streptavidin-Peroxidase Conjugate were added per well and    incubated at 
room temperatures for 30 minutes. The bioelisa reader ELx 800 (biokit, U.S.A)   was 
turned on and set up the program in advance. 
 The microplate was washed as described above. 
 Were μl of Chromogen Substrate were added per well and incubated at room 
temperatures for about 15 minutes or until the optimal blue color density develops. 
 Fifty μl of Stop Solution were added to each well. The color will change from blue to 
yellow. The absorbance on bioelisa reader ELx 800 was read at a wavelength of 450 nm 
immediately. Results were provided within 1 minute on the LCD display. 
Calculation of results: 
Results were calculated using standard concentration curve. The standard curve measures 
the relationship between optical density (O.D) and standard (ng/ml) and the results were 
interpolated using Graphpad prism. The correlation coefficient (r) was 0.8998. 
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Fig (1-1): IFN-γ standard curve. 
 
Granulocyte, monocyte- colony stimulation factors (GM-CSF): 
The RayBio Human GM-CSF ELISA kit was performed according to the manufacturing 
company (RayBiotech, Inc. U.S.A) as follows: 
1. The components of the kits were equilibrated at room temperature before use. 
2. The components of the kits were prepared as follows: 
 
Reagents Preparation 
GM-CSF Microplate 96 wells ready to use 
Wash Buffer concentration Dilute 20ml in 400ml of D.W. 
Assay Diluent Antibody GM-CSF Dilute  6 ml  in 24 ml D.W. 
Human GM-CSF standards(100ng/ml) 
Adding 5μl of GM-CSF standard to tube with 995 μl  
of Assay Diluent to generate a 500pg/ml of solution 
 Biotinylated Antihuman GM-CSF 
Adding 100 μl of Assay Diluent into the vial then 
mix solution with 12 ml Assay Diluent 
HRP-Streptavidin concentrate 
Adding 2 μl of HRP-Streptavidin concentrate in to 
tube with 198 μl Assay Diluent and then pipette 60 
μl in to tube with 6 ml Assay Diluent. 
TMB One-Step Substrate Reagent 12ml ready to use 
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3. The standard solution and the appropriate diluents were prepared as follows: 
Standard point Dilution 
GM-CSF concentration 
(Pg/ml) 
P1 Standard (500 pg/ml) 500.0 
P2 1 part P1 + 1.5 part Assay Diluent 200.0 
P3 1 part P2 + 1.5 part Assay Diluent 80.0 
P4 1 part P3 + 1.5 part Assay Diluent 32.0 
P5 1 part P4 + 1.5 part Assay Diluent 12.80 
P6 1 part P5 + 1.5 part Assay Diluent 5.12 
P7 1 part P6 + 1.5 part Assay Diluent 2.05 
P8 Assay  Diluent 0.00 
 
Procedure: 
 One hundred μl of Standard (8), controls (20) and samples (70) was added per assigned 
well. Wells were covered with a sealing tape and incubated for 2.5 hours at room 
temperature with gentle shaking. The timer was started after the last sample addition. 
 The microplate was washed four times with 300 μl of Wash Buffer/well using bioeliser 
washer ELx 50 (biokit, U.S.A) 
 One hundred μl of Biotinylated anti GM-CSF antibody were added to each well and 
incubated for one hour at room temperature with gentle shaking. 
 The microplate was washed as described above. 
 Streptavidin   solution (One hundred μl) / per well were added and incubated for 45 
minutes at room temperature with gentile shaking. The microplate was washed as 
described above. 
 TMB One-Step Substrate Reagent (One hundred μl ) were added to each well  and 
incubate for 30 minutes at room temperature in the dark with shaking. The bioelisa reader 
ELx 800 (biokit, U.S.A) was turned on and set up the program in advance. 
 Stop Solution (fifty μl) were added to each well. The color will change from blue to 
yellow. The absorbance on bioelisa reader ELx 800 was read at a wavelength of 450 nms 
immediately. Results were provided within 1 minute on the LCD display. 
Calculation of results: 
Results were calculated using standard concentration curve. The standard curve measures 
the relationship between optical density (O.D) and standard (pg/ml) and the results were 
interpolated using Graphpad prism. The correlation coefficient (r) was 0.9558. 
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The study showed a higher significant increase (p > 0.0001) in the level  of INF-γ in all 
groups of patients suffering from chronic or recurrent  tonsillitis than the healthy control group. 
However it's less significant in D-1 and D-4 (Figure 1-3) 
 
Figure (1-3): Level of INF-γ in all studied groups of tonsillitis patients compared with healthy 
control group.  
 
 Data are expressed as mean ±  standard error (SE) 
 The asterisks indicate significant difference compared to control based on Tukey's 
multiple comparison test. 
 Ns: not significant. 
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 A1: the group of patients with the age (>5) years. 
 A2: the group of patients with the age (6-10) years. 
 A3: the group of patients with the age (11-15) years. 
 A4: the group of patients with the age (16-20) years. 
 A5: the group of patients with the age (21-25) years. 
 A6: the group of patients with the age ( < 26) years. 
 D1: the group of patients with disease duration of (˂1) years. 
 D2: the group of patients with disease duration of (2-3) years. 
 D3: the group of patients with disease duration of (4-5) years. 
 D4: the group of patients with disease duration of (6-7) years. 
 D5: the group of patients with disease duration of ((˃ 8) years. 
 S1: female group. 
 S2: male group.  
 
GM-CSF 
According to the result of our study there was increase in level of GM-CSF in all groups 
of patients suffering from tonsillitis in comparison to the healthy control group and this increase 
was statistically significant in all groups (Figure 4-8).  
 
Figure (1-4): Level of GM-CSF in the studied groups compared to healthy control group.  
 Data are expressed as mean ±  standard error (SE) 
 The asterisks indicate significant difference compared to control based on Tukey's 
multiple comparison test. 
 
4- DISSCUSION 
. Serum Levels of IFN-γ 
The current study revealed that the serum concentrations of IFN-γ were significantly 
elevated in tonsillitis patients compared to those in healthy control group as seen in previous 
reports. 
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IFN-γ was originally discovered because of its ability to induce cell to block or inhibit 
the replication of a wide variety of viruses and play a central role in many immunoregulatory 
processes including mononuclear phagocyte, B cell switching to certain IgG and inhibition of 
Th-cell subset. 
    Emphasizing the role of IFN-γ as a major cytokine in infection mononucleosis. High 
levels of IFN- γ are expressed by TH1cells, activating macrophages to kill microbes, promoting 
cytotoxic activities of other cells, and inducing apoptosis of epithelial cells in the skin and 
mucosa [5]. 
 The current study exhibited that INF-γ was commonly detectable in all cases of 
tonsillitis. Together with detectable cytokines, namely, IL-4, IL-1α, IL-10, these cytokines 
correlate with EBV infection. 
 
Serum Levels of GM-CSF 
Serum levels of GM-CSF were significantly elevated in all groups of patient with 
tonsillitis compared with healthy control group.  
GM-CSF may stimulate the hematopoietic regeneration and the functional activity of 
granulocyte and monocyte, GM-CSF substantially enhanced the antiviral activity thus 
improving the immune status of patients which is implicated in the pathogenesis of the disease.  
[6].  reported that the elevation of GM-CSF IFN-γ, IL-4, and IL-10 may also be 
responsible for the clinical symptoms in chronic IM caused by EBV.  
 However, [7].  reported that increase secretion of GM-CSF, ILI-α, IL-4, INF-γ, and IL-
10 with EBV infection of tonsils, during the initial response to EBV infection, the innate 
immune response is capable of suppressing viral replication more efficiently than is the adaptive 
immune response. 
 
5-  Conclusion: 
From this study we can conclude the following; 
1. The serum levels of proinflammatory cytokines IFNγ, GM-CSF, play a major role in the 
pathogenesis of tonsillitis, as part of the immune defense. 
 
2. The association of IFNγ, and GM-CSF its effect on different component of cell mediated 
immunity by increasing or decreasing according to site of activity and other 
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